Today's huge buying may have been by insiders who know that
Today's huge buying may have been by insiders who know that there is about to be an announcement on the first acquisition as it wasn't by former bidders of the 128M that was there at the open.
It wasn't a spoof bid - as it didn't get cancelled when the initial .0003s went - and has been increased to 208M and stayed like that. Bids have consistently been in the 128M > 199M range for several days now.
The additional volume at .0003 was from a few 1-tick flippers who managed to get relatively large amounts at .0002 in a single day a few months back when there was still some dilution - none for 79 days now. From their previous comments it is known they also have .0003s and so were just converting more of those to effectively free.
We should see the .0004s start as soon as some of the new bidders commit to buying on the ask so as not to get left behind.
Main buys were 5M then 80M in a few individual seconds - then additional 5M/10M buys for 119M total (some of which were on the bid at .0003).
Looking good now for continued action in the weeks ahead now we have a lot more eyes on it.
SFLMaven, Inc. (SFLM) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...
Continue Reading
A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...
Continue Reading
Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...
Continue Reading
Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...
Continue Reading
Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...
Continue Reading
The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...
Continue Reading
Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....
Continue Reading
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue Reading
Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...
Continue Reading
Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...
Continue Reading
Top 5 Most Recently Viewed Articles
Targa Resources Corp. Engages in Key Energy Conference Activities HOUSTON — Targa Resources Corp. (NYSE: TRGP) has announced its participation in the upcoming BofA Securities Global Energy Conference. This lively event provides a platform for engaging with investors and showcasing the company’s strategic vision in the midstream sector. Details About the Conference...
Continue Reading
Understanding Recent Options Activity of Bit Digital Financial institutions are taking noticeable bearish stances on Bit Digital. A thorough examination of the options history for Bit Digital (NASDAQ: BTBT) reveals a total of 25 unusual trades, warranting a closer look into their implications. Trends in Trader Sentiment Upon delving into trader behaviors, our analysis...
Continue Reading
Overview of IGEL's 2025 Innovations In a pivotal showcase at its flagship event, IGEL unveiled more than 20 innovative advancements aimed at transforming secure endpoint computing. These innovations reflect IGEL's commitment to providing enhanced security, compliance, and flexibility at a time when organizations face increasing cyber threats and operational complexities....
Continue Reading
Andelyn Biosciences Expands Gene Therapy Offerings Andelyn Biosciences, Inc., a prominent player in the cell and gene therapy sector, has made a significant enhancement to its AAV Curator™ Platform. This development comes through a licensing agreement with the Broad Institute of MIT and Harvard, incorporating the highly anticipated Stanton Lab CNS (Central Nervous...
Continue Reading
Berkshire Hathaway's Q2 13F Filing Insights Warren Buffett and Berkshire Hathaway Inc (NYSE: BRK) are facing a crucial period as they approach an important 13F filing that could unveil their investment strategy for the near future. This filing is pivotal as it will provide insights into which positions the company has increased or decreased, shedding light on the overall...
Continue Reading